News Daily News Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Caitlin E. Cox October 22, 2025
News Daily News ‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials Michael O'Riordan February 20, 2025
News Daily News FDA Approves Cordella Remote PA Pressure Monitoring System for HF Yael L. Maxwell June 24, 2024
News Daily News FDA Extends MitraClip Indication to Include Functional MR Shelley Wood March 14, 2019
News Daily News FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients Yael L. Maxwell December 05, 2018
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018